GSG-US, Inc.     
Experience      
 Phase 3 Trials:

  • Anti-Infection study (Sepsis):Development and creation of Mock tables, SDTM (mapping, xpt, define.xml, blank.crf), ADaM, TLGs. DMC and CEC ad-hoc analysis
  • Gastrointestinal study (Proton pump inhibitors extended release): Creation of Mock Tables, SDTM, ADaM.
  • Seizure: SDTM (mapping, xpt, define.xml, blank.crf)




  •  Phase 2 Trials:

  • Coronary Artery Disease (CAD): Ad-Hoc analysis
  • Acute Coronary Syndrome (ACS): Ad-Hoc analysis
  • Seizure: Creation of ADaM, TLGs
  • Psoriasis: Ad-Hoc analysis, Data check




  •  Phase 1 Trials:

  • Oncology: Development of CRF, SAP, SDTM, ADaM, TLGs, DMC, CSR
  • Flu vaccine: Development of SAP, TLGs




  •  CDISC:
  • Creation of Phase 2, 3 trials (Creation of SAS XPT files, define.xml, blank.pdf, data mapping)
  • Validation of Phase 1 trial (CDISC compliance, data value checks raw vs. SDTM)


  • GSG-US, Inc.

    30 Goldenrod Drive
    Belle Mead, NJ 08502
    ph: 609-269-2646
    Ph (Korea): 070-7885-5591
    alt: 908-531-6858
    chaeyong.chang@gsg-us.com
    Copyright 2012 GSG-US, Inc. All rights reserved.